Dabrafenib |
达拉非尼 |
1195765-45-7 |
STAT3 Inhibitor VII - CAS 1041438-68-9 - Calbiochem |
STAT3 Inhibitor VII - CAS 1041438-68-9 - Calbiochem |
1041438-68-9 |
Niraparib |
尼拉帕尼 |
1038915-60-4 |
UNC3230 |
UNC3230 |
1031602-63-7 |
MHAPC-Chol |
MHAPC-CHOL |
1027801-74-6 |
(+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM |
LORGLUMIDE SODIUM SALT |
1021868-76-7 |
EpigeneticMultipleLigand |
EPIGENETIC MULTIPLE LIGAND |
1020399-52-3 |
TG4-155 |
TG4-155; TG-4-155; TG 4-155; TG4155; TG-4155; TG 4155 |
1164462-05-8 |
1-[4-[(2,3,3-Trichloro-1-oxo-2-propen-1-yl)amino]phenyl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylicacid |
1160514-60-2 |
1160514-60-2 |
E-7449 |
1140964-99-3 |
1140964-99-3 |
Dacomitinib (PF299804) |
达克替尼 |
1110813-31-4 |
Pyrene phosphoramidite dU |
Pyrene phosphoramidite dU |
199920-17-7 |
ACPT-I |
化合物 T22549 |
194918-76-8 |
5-METHOXYCARBONYLAMINO-N-ACETYLTRYPTAMINE |
N-甲氧基羰基琥珀酰亚胺 |
190277-13-5 |
BAY 80-6946 (Copanlisib) |
库潘尼西 |
1032568-63-0 |
HX 531 |
HX 531 |
188844-34-0 |
Ceritinib (LDK378) |
色瑞替尼 |
1032900-25-6 |
MK-8245 |
MK-8245 |
1030612-87-3 |
3-[1-(3-Hydroxy-4-methoxyphenyl)-meth-(E)-ylidene]-6-methyl-chroman-4-one |
3-[1-(3-Hydroxy-4-methoxyphenyl)-meth-(E)-ylidene]-6-methyl-chroman-4-one |
1031206-36-6 |
Albaconazole |
阿巴康唑 |
187949-02-6 |